CAI Competitors & Alternatives
Compare Caris Life Sciences, Inc. Common Stock with similar stocks in the same industry
Biotechnology
CAI
Main Stock$16.91
Tradestie Score
51
Market Cap
$8.53B
Revenue Growth
0.8%
Analyst Upside
+62.1%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$25.78
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$51.22
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 59 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$227.79
|
$5.92B | - | 60 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$55.04
|
$5.80B | 20.0 | 61 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$362.44
|
$5.20B | 50.3 | 60 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$57.31
|
$4.94B | - | 60 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$81.07
|
$4.93B | - | 63 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$73.35
|
$4.84B | - | 46 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
More CAI Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 8071)
237 stocks in this industry